Previous studies have reported that CDX2-negative colon cancer is associated with poor prognostic factors such as advanced stage, poorly differentiated cancer, vascular invasion, BRAF mutation, and CIMP positive status [33, 36–39]. This evidence concerns the gene CDX2 and malignant colon neoplasm.